Literature DB >> 8105983

Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia.

G Otto1, T Sandberg, B I Marklund, P Ulleryd, C Svanborg.   

Abstract

Bacteremia develops in a subgroup of patients with acute pyelonephritis. This study examined isolates of Escherichia coli from the urine and the blood of 25 bacteremic and 67 nonbacteremic women with this acute disease. P-fimbriated strains were found in 100% of bacteremic patients without complicating factors but in only 71% of nonbacteremic patients without complications (P < .05). Non-P-fimbriated strains were only found to cause bacteremia in three patients with compromising host factors. Strains from the bacteremic group and those from the nonbacteremic group did not differ significantly in terms of hemolysin or aerobactin production or of serum resistance. The P-fimbriated strains from both groups of patients carried pap DNA sequences of the papGIA2 adhesin type; prsGJ96 homologous DNA sequences were rare. The results suggested that P fimbriae and compromising host conditions independently increase the risk for bacteremia during acute pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105983     DOI: 10.1093/clinids/17.3.448

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia.

Authors:  Stéphane Bonacorsi; Véronique Houdouin; Patricia Mariani-Kurkdjian; Farah Mahjoub-Messai; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  papG alleles among Escherichia coli strains causing urosepsis: associations with other bacterial characteristics and host compromise.

Authors:  J R Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG.

Authors:  J R Johnson; A E Stapleton; T A Russo; F Scheutz; J J Brown; J N Maslow
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.

Authors:  Priscila Reina Siliano; Lillian Andrade Rocha; José Osmar Medina-Pestana; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

5.  Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.

Authors:  Jonas Marschall; Lixin Zhang; Betsy Foxman; David K Warren; Jeffrey P Henderson
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

6.  Shock due to urosepsis: A multicentre study.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Koichi Kitagawa; Kei Takaba; Issei Tokimatsu; Soichi Arakawa; Masato Fujisawa
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

7.  Novel molecular variants of allele I of the Escherichia coli P fimbrial adhesin gene papG.

Authors:  J R Johnson; A L Stell; N Kaster; C Fasching; T T O'Bryan
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III.

Authors:  J R Johnson; T T O'Bryan; D A Low; G Ling; P Delavari; C Fasching; T A Russo; U Carlino; A L Stell
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.

Authors:  Hans Fischer; Nataliya Lutay; Bryndís Ragnarsdóttir; Manisha Yadav; Klas Jönsson; Alexander Urbano; Ahmed Al Hadad; Sebastian Rämisch; Petter Storm; Ulrich Dobrindt; Ellaine Salvador; Diana Karpman; Ulf Jodal; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

10.  Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.

Authors:  James A Roberts; M Bernice Kaack; Gary Baskin; Matthew R Chapman; David A Hunstad; Jerome S Pinkner; Scott J Hultgren
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.